In October 2025, Governor Gavin Newsom signed two sweeping legal guidelines that considerably reshape how healthcare transactions are reported and the way personal fairness teams and hedge funds might have interaction with doctor and dental practices. Meeting Invoice 1415 (AB 1415) establishes new reporting obligations for healthcare transactions involving materials adjustments in possession or management, whereas Senate Invoice 351 (SB 351) codifies California’s Company Observe of Medication (CPOM) doctrine by proscribing how personal fairness teams and hedge funds might affect or management medical practices. Each legal guidelines take impact on January 1, 2026, with AB 1415’s reporting necessities making use of to transactions closing on or after April 1, 2026.
AB 1415: Increasing Oversight in Healthcare Transactions
AB 1415 updates Well being and Security Code §127501 (HSC §127501) and §127507 (HSC §127507) to create a proper pre-transaction discover course of for sure healthcare transactions involving a “materials” switch of property or operational management. As amended, HSC §127507 requires healthcare entities, administration companies organizations (MSOs), and different events to offer written discover to the Division of Well being Care Entry and Data (HCAI) at the least 90 days earlier than coming into right into a lined settlement or transaction.
The statute imposes two distinct discover obligations:
- Healthcare entities should report transactions through which they switch a cloth quantity of their very own property or operational management to a different celebration.
- Noticing entities, reminiscent of personal fairness teams, hedge funds, MSOs, or different affiliated entities, should report transactions involving the switch of a cloth quantity of property or management over a healthcare entity or MSO.
HSC §127507 particularly requires MSOs to offer discover of any such transaction between the MSO and one other entity. This displays a transparent recognition of MSOs’ rising position in managing and structuring supplier practices.
Notably, the regulation doesn’t outline what constitutes a “materials quantity” of property or operational management. As an alternative, HCAI is tasked below HSC §127501 with issuing rules that can make clear key thresholds, reminiscent of annual income, market share, or geographic impression. HCAI can be anticipated to streamline reporting to keep away from duplication when a number of events to the identical transaction would in any other case be required to submit discover.
Whereas the updates to HSC §127501 don’t authorize HCAI to approve or block transactions, they do require the company to play a extra energetic position in monitoring healthcare consolidation. Beneath sure circumstances, reminiscent of when a proposed transaction might have an effect on market competitors, entry to companies, or prices, HCAI is required to make the transaction discover and associated supplies publicly accessible. The company can be anticipated to difficulty rules governing further disclosures and evaluation thresholds, which can embrace processes for requesting supplemental data from the events concerned.
In sensible phrases, HSC §127501 and HSC §127507 set the muse for a statewide reporting infrastructure round healthcare transactions. Organizations ought to start making ready for longer transaction timelines and consider whether or not upcoming offers might set off reporting obligations, particularly these closing in mid-2026 or later.
SB 351: Codifying the Company Observe of Medication Doctrine and Limiting Investor Management
SB 351 updates Well being and Security Code §1190 (HSC §1190) and §1191 (HSC §1191) to codify and broaden California’s Company Observe of Medication doctrine by proscribing the flexibility of personal fairness teams and hedge funds to affect or management medical decision-making inside doctor and dental practices. This is applicable to any personal fairness group or hedge fund “concerned in any method” with a doctor or dental observe doing enterprise in California. This contains not solely direct possession but in addition involvement by means of asset purchases, MSO buildings, or oblique company affiliations. The regulation’s broad phrasing displays the Legislature’s intent to manage the complete spectrum of monetary and operational preparations that will have an effect on medical autonomy. Importantly, SB 351 doesn’t grandfather present MSO preparations or contracts; all present and future agreements should adjust to the brand new statutory necessities as of the regulation’s efficient date.
Beneath HSC §1191, traders are prohibited from interfering with skilled medical judgment, together with choices about diagnostic testing, referrals, remedy choices, affected person scheduling, and total accountability for affected person care.
The regulation additionally bars personal fairness teams and hedge funds from exercising management over key facets of observe operations. These embrace:
- Possession or management of affected person medical information.
- Hiring or firing medical employees based mostly on medical competency or proficiency.
- Setting parameters for payer or supplier contracts.
- Making choices about billing, coding, or the number of medical tools and provides.
Maybe most consequentially, adjustments to HSC §1191 render sure contract phrases in administration or asset sale agreements with a non-public fairness group, hedge fund or their managed entities unenforceable. These embrace:
- Provisions that allow the sorts of medical or operational management described above.
- Noncompete clauses that bar a doctor or dentist from competing with the observe following termination or resignation.
- Non-disparagement clauses that prohibit suppliers from commenting on high quality of care, utilization practices, moral considerations, or enterprise pressures.
Sale-of-business noncompete provisions stay legitimate below California regulation. Confidentiality agreements are nonetheless enforceable, however solely to the extent they don’t restrict disclosures about medical high quality or skilled ethics. The statute applies whatever the observe’s authorized construction and extends to entities instantly or not directly managed by personal fairness teams or hedge funds.
The amendments of HSC §1190 and HSC §1191 reaffirm the independence of licensed suppliers and units new compliance expectations that can have an effect on how practices are structured, managed, and supported by exterior traders. Healthcare professionals, notably these affiliated with MSOs or personal fairness teams, might need to evaluation present agreements to evaluate whether or not revisions are wanted below the brand new regulation.
What This Means for Authorized, Compliance, and Funding Groups
AB 1415 and SB 351 introduce new compliance, authorized, and strategic concerns for healthcare traders, deal groups, and advisors concerned in observe acquisitions or administration.
Beneath AB 1415, organizations might want to construct a 90-day lead time into transaction timelines and put together to have interaction with a brand new state evaluation course of, although formal approvals aren’t required. Inner procedures ought to be up to date to determine doubtlessly reportable transactions early within the deal cycle. Counsel and deal groups must also take into account constructing regulatory evaluation contingencies into timelines for 2026 transactions and past
Beneath SB 351, authorized groups ought to start auditing present MSO agreements, asset buy buildings, and operational contracts to make sure compliance. Explicit consideration ought to be paid to governance rights, medical decision-making authority, and any restrictive covenants imposed on suppliers. In some instances, contractual fashions might should be restructured to align with the brand new statutory boundaries.
In each instances, additional steering is anticipated. HCAI and the Lawyer Basic’s Workplace are anticipated to difficulty rules and implementation supplies in 2026. Organizations ought to monitor these developments carefully and take into account submitting feedback throughout the rulemaking course of if the chance arises.
Collectively, AB 1415 and SB 351 signify a serious shift in California’s regulation of healthcare transactions and investor affect. AB 1415 establishes a proper discover course of for materials offers, whereas SB 351 attracts clear authorized boundaries round medical management. With each legal guidelines taking impact in 2026, healthcare organizations and traders ought to start reviewing their deal buildings and compliance frameworks now to keep away from potential regulatory points down the road.
In case you have any questions concerning the implementation of AB 1415 or SB 351, please contact Jonathan Dolgin.